Interaction between years of education and APOE ε4 status on frontal and temporal metabolism

Neurology

Volumn 85, Issue 16, 2015, Pages 1392-1399

  Arenaza Urquijo, Eider M ^a,b,c,d   Gonneaud, Julie ^a,b,c,d   Fouquet, Marine ^a,b,c,d   Perrotin, Audrey ^a,b,c,d   Mézenge, Florence ^a,b,c,d   Landeau, Brigitte ^a,b,c,d   Egret, Stéphanie ^a,d   De La Sayette, Vincent ^a,b,c,d   Desgranges, Béatrice ^a,b,c,d   Chételat, Gaël ^a,b,c,d  

^a Centre Cyceron   (France)

^b UNIVERSITÉ DE CAEN   (France)

^c PSL RESEARCH UNIVERSITY   (France)

^d CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 4; UNCLASSIFIED DRUG; APOLIPOPROTEIN E4;

ADULT; AGED; ARTICLE; BRAIN METABOLISM; BRAIN SIZE; COGNITIVE RESERVE; CONTROLLED STUDY; EPISODIC MEMORY; FEMALE; FRONTAL LOBE; GRAY MATTER; HUMAN; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; MEDIAL TEMPORAL LOBE; METABOLISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TEMPORAL LOBE; EDUCATION; EDUCATIONAL STATUS; GENETICS; HETEROZYGOTE; MIDDLE AGED; TIME FACTOR; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; EDUCATION; EDUCATIONAL STATUS; FEMALE; FRONTAL LOBE; HETEROZYGOTE; HUMANS; MALE; MEMORY, EPISODIC; MIDDLE AGED; TEMPORAL LOBE; TIME FACTORS; YOUNG ADULT;

EID: 84944789869     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002034     Document Type: Article

References (38)

1. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele, and the risk of alzheimer's disease in late onset families. Science 1993; 261: 921-923
2. Saunders AM, Schmader K, Breitner JC, et al. Apolipoprotein E epsilon 4 allele distributions in late-onset alzheimer's disease, and in other amyloid-forming diseases. Lancet 1993; 342: 710-711
3. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial, and sporadic Alzheimer's disease. Neurology 1993; 43: 1467-1472
4. Wang HX, Gustafson DR, Kivipelto M, et al. Education halves the risk of dementia due to apolipoprotein e4 allele: a collaborative study from the Swedish brain power initiative. Neurobiol Aging 2012; 33: 1007.e1-1007.e7
5. Ferrari C, Xu WL, Wang HX, et al. How can elderly apolipoprotein E e4 carriers remain free from dementia?. Neurobiol Aging 2013; 34: 13-21
6. Meng X, D'Arcy C. Apolipoprotein E gene, environmental risk factors, and their interactions in dementia among seniors. Int J Geriatr Psychiatry 2013; 28: 1005-1014
7. Wirth M, Villeneuve S, La Joie R, Marks SM, Jagust WJ. Gene-environment interactions: lifetime cognitive activity, APOE genotype, and beta-amyloid burden. J Neurosci 2014; 34: 8612-8617
8. Fouquet M, Besson FL, Gonneaud J, La Joie R, Chételat G. Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan. Neuropsychol Rev 2014; 24: 290-299
9. Arenaza-Urquijo EM, Landeau B, La Joie R, et al. Relationships between years of education, and gray matter volume, metabolism, and functional connectivity in healthy elders. Neuroimage 2013; 83: 450-457
10. Ewers M, Insel PS, Stern Y, Weiner MW. Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease. Neurology 2013; 80: 1194-1201
11. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification, and cleavage with HhaI. J Lipid Res 1990; 31: 545-548
12. La Joie R, Perrotin A, Barré L, et al. Region-specific hierarchy between atrophy, hypometabolism, and b-amyloid (Ab) load in alzheimer's disease dementia. J Neurosci 2012; 32: 16265-16273
13. Morbelli S, Perneczky R, Drzezga A, et al. Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European alzheimer disease consortium project. J Nucl Med 2013; 54: 894-902
14. Eustache F, Desgranges B, Lalevée C. Clinical evaluation of memory [in French]. Rev Neurol 1998; 154(suppl 2): S18-S32
15. Signoret JL, Benoit N. Examination, and memory [in French]. Rev Prat 1991; 41: 866-868
16. Scarmeas N, Zarahn E, Anderson KE, et al. Cognitive reserve-mediated modulation of positron emission tomographic activations during memory tasks in alzheimer disease. Arch Neurol 2004; 61: 73-78
17. Brown BM, Peiffer JJ, Taddei K, et al. Physical activity, and amyloid-b plasma, and brain levels: results from the Australian Imaging, Biomarkers, and Lifestyle Study of Ageing. Mol Psychiatry 2013; 18: 875-881
18. Head D, Bugg JM, Goate AM, et al. Exercise engagement as a moderator of the effects of APOE genotype on amyloid deposition. Arch Neurol 2012; 69: 636-643
19. Kivipelto M, Rovio S, Ngandu T, et al. Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a populationbased study. J Cell Mol Med 2008; 12: 2762-2771
20. Rovio S, Kåreholt I, Helkala EL, et al. Leisure-time physical activity at midlife, and the risk of dementia, and alzheimer's disease. Lancet Neurol 2005; 4: 705-711
21. Arenaza-Urquijo EM, Molinuevo JL, Sala-Llonch R, et al. Cognitive reserve proxies relate to gray matter loss in cognitively healthy elderly with abnormal cerebrospinal fluid amyloid-b levels. J Alzheimers Dis 2013; 35: 715-726
22. Lo RY, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative. Effect of cognitive reserve markers on alzheimer pathologic progression. Alzheimer Dis Assoc Disord 2013; 27: 343-350
23. Mormino EC. The relevance of Beta-amyloid on markers of alzheimer's disease in clinically normal individuals, and factors that influence these associations. Neuropsychol Rev 2014; 24: 300-312
24. Barulli D, Stern Y. Efficiency, capacity, compensation, maintenance, plasticity: emerging concepts in cognitive reserve. Trends Cogn Sci 2013; 17: 502-509
25. Landau SM, Marks SM, Mormino EC, et al. Association of lifetime cognitive engagement, and low b-amyloid deposition. Arch Neurol 2012; 69: 623-629
26. Liang KY, Mintun MA, Fagan AM, et al. Exercise, and alzheimer's disease biomarkers in cognitively normal older adults. Ann Neurol 2010; 68: 311-318
27. Stern Y. What is cognitive reserve?. Theory, and research application of the reserve concept. J Int Neuropsychol Soc 2002; 8: 448-460
28. Reiman EM, Chen K, Alexander GE, et al. Functional brain abnormalities in young adults at genetic risk for late-onset alzheimer's dementia. Proc Natl Acad Sci USA 2004; 101: 284-289
29. Reiman EM, Caselli RJ, Yun LS, et al. Preclinical evidence of alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 1996; 334: 752-758
30. Small GW, Ercoli LM, Silverman DH, et al. Cerebral metabolic, and cognitive decline in persons at genetic risk for alzheimer's disease. Proc Natl Acad Sci USA 2000; 97: 6037-6042
31. Small GW, Mazziotta JC, Collins MT, et al. Apolipoprotein E type 4 allele, and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 1995; 273: 942-947
32. Yoshizawa H, Gazes Y, Stern Y, Miyata Y, Uchiyama S. Characterizing the normative profile of 18F-FDG PET brain imaging: sex difference, aging effect, and cognitive reserve. Psychiatry Res 2014; 221: 78-85
33. Cohen AD, Price JC, Weissfeld LA, et al. Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. J Neurosci 2009; 29: 14770-14778
34. Reiman EM, Chen K, Liu X, et al. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for alzheimer's disease. Proc Natl Acad Sci USA 2009; 106: 6820-6825
35. Wolf AB, Valla J, Bu G, et al. Apolipoprotein E as a b-amyloid-independent factor in alzheimer's disease. Alzheimers Res Ther 2013; 5: 38
36. Shaw P, Lerch JP, Pruessner JC, et al. Cortical morphology in children, and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol 2007; 6: 494-500
37. Alexopoulos P, Richter-Schmidinger T, Horn M, et al. Hippocampal volume differences between healthy young apolipoprotein E e2, and e4 carriers. J Alzheimers Dis 2011; 26: 207-210
38. Jagust WJ, Landau SM; Alzheimer's Disease Neuroimaging Initiative. Apolipoprotein E, not fibrillar b-amyloid, reduces cerebral glucose metabolism in normal aging. J Neurosci 2012; 32: 18227-18233